| 1 |
35151832 | PHLPP1 deficiency ameliorates cardiomyocyte death and cardiac dysfunction through inhibiting Mcl-1 degradation. | 2022 Apr |
2 |
| 2 |
33639139 | Anti-CD19 mAb modified mesoporous titanium dioxide as exclusively targeting vector for efficient B-lymphoblastic leukemia therapy. | 2021 Jul |
1 |
| 3 |
33670870 | Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling. | 2021 Feb 28 |
1 |
| 4 |
34689155 | Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p. | 2021 Oct 23 |
1 |
| 5 |
32801295 | Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance. | 2020 Aug 15 |
1 |
| 6 |
30562553 | Differential effects of protein kinase C-eta on apoptosis versus senescence. | 2019 Mar |
1 |
| 7 |
28947136 | BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis. | 2018 Jan 1 |
1 |
| 8 |
30119255 | Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis. | 2018 Oct |
2 |
| 9 |
30417787 | Molecular Effects of Treatment of Human Colorectal Cancer Cells with Natural and Classical Chemotherapeutic Drugs: Alterations in the Expression of Apoptosis-related BCL2 Family Members, Including BCL2L12. | 2018 |
1 |
| 10 |
28714472 | Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy. | 2017 Jul 17 |
1 |
| 11 |
26680268 | A NOXA/MCL-1 Imbalance Underlies Chemoresistance of Malignant Rhabdoid Tumor Cells. | 2016 Sep |
2 |
| 12 |
26718267 | MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1. | 2016 Feb |
2 |
| 13 |
26892009 | Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells. | 2016 May |
2 |
| 14 |
25894378 | The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer. | 2015 Sep |
2 |
| 15 |
26425662 | Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage. | 2015 |
1 |
| 16 |
26473375 | JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis. | 2015 Nov 10 |
1 |
| 17 |
26526790 | miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1. | 2015 |
4 |
| 18 |
24814395 | Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA. | 2014 Aug 28 |
1 |
| 19 |
22752851 | Protective effect of plaunotol against doxorubicin-induced renal cell death. | 2013 Apr |
2 |
| 20 |
23449477 | Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells. | 2013 Mar |
3 |
| 21 |
22314265 | Noxa/Mcl-1 balance influences the effect of the proteasome inhibitor MG-132 in combination with anticancer agents in pancreatic cancer cell lines. | 2012 Jul |
1 |
| 22 |
22457358 | α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). | 2012 May 18 |
2 |
| 23 |
22581584 | ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma. | 2012 Oct |
1 |
| 24 |
20856197 | PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis. | 2011 Jan 27 |
2 |
| 25 |
17653083 | A pivotal role for Mcl-1 in Bortezomib-induced apoptosis. | 2008 Jan 31 |
1 |
| 26 |
18818206 | Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. | 2008 Nov 28 |
1 |
| 27 |
17147248 | [Reversal of multi-drug resistance in K562/A02 cells by two short hairpin RNAs (shRNA) of mdr1]. | 2006 Jul |
4 |